国新健康(000503) - 2020 Q3 - 季度财报

Financial Performance - Operating revenue for the reporting period reached CNY 28,857,583.08, representing a 30.15% increase compared to the same period last year[9]. - Net profit attributable to shareholders of the listed company was a loss of CNY 42,409,901.84, which is a 25.23% increase in loss compared to the previous year[9]. - The company reported a total loss of ¥22,841,011.95 in the current period[39]. - The net loss for the current period was ¥42,753,464.34, compared to a net loss of ¥35,099,801.07 in the previous period, reflecting a deterioration of approximately 21.3%[85]. - The company reported a total profit of -¥162,920,237.19 for the current period, compared to -¥147,396,706.77 in the previous period, indicating a decrease of about 10.0%[100]. - The comprehensive loss for the current period was ¥55,588,361.19, compared to a loss of ¥40,275,470.70 in the previous period, indicating an increase in losses of approximately 38.0%[89]. Assets and Liabilities - Total assets at the end of the reporting period amounted to CNY 1,680,311,445.89, a decrease of 9.74% compared to the previous year[9]. - The total assets decreased from ¥1,680,311,445.89 to ¥1,516,593,568.75, a decline of approximately 9.75%[72]. - Current liabilities increased significantly from ¥77,726,675.67 to ¥462,509,296.89, representing a rise of approximately 493.36%[69]. - The total liabilities amounted to ¥644,184,911.30, compared to ¥209,649,876.17 in the previous period, showing a substantial increase of approximately 207.5%[79]. - The total owner's equity decreased from ¥1,602,584,770.22 to ¥1,054,084,271.86, a decline of approximately 34.3%[72]. Shareholder Information - Net assets attributable to shareholders of the listed company were CNY 1,598,298,488.40, reflecting a decline of 34.24% year-on-year[9]. - The top ten shareholders held a total of 26.22% of shares, with the largest shareholder, China Oceanwide Holdings Group Co., Ltd., owning 235,702,593 shares[15]. - The company’s actual controller and shareholders have made commitments regarding share reduction and performance targets[35]. - The company aims for a net profit growth rate of no less than 30% over three consecutive years to trigger share reduction conditions[35]. Cash Flow - The net cash flow from operating activities was a negative CNY 21,414,948.79, showing an improvement of 16.69% compared to the same period last year[9]. - Cash flow from operating activities shows a net outflow of -131,917,586.91, slightly improved from -141,840,199.66 in the previous period[114]. - Cash inflow from investment activities is 1,289,494.37, compared to 905,488.16 in the previous period, indicating an increase in cash received from investments[117]. - The ending cash and cash equivalents balance is 598,173,481.88, compared to 461,552,071.12 in the previous period, indicating an increase in liquidity[117]. Expenses - Sales expenses rose by 36.87% to RMB 14,762,776.62, driven by increased business activities[26]. - Financial expenses decreased by 84.71% to -RMB 2,412,231.57, primarily due to lower interest income[26]. - R&D expenses fell by 59.94% to RMB 12,178,173.52, as previous periods had concentrated R&D projects[27]. - Research and development expenses increased significantly to ¥4,979,239.21 from ¥1,572,108.17, marking a rise of about 216.5%[82]. Acquisitions and Investments - The acquisition of a 99.01% partnership interest in Shenzhou Borui was completed for a transaction price of RMB 376 million, adjusted to RMB 356 million due to existing debts[33]. - The company paid a sincerity deposit of RMB 50 million to the major shareholder of Jingyi Technology to facilitate the acquisition process[29]. - The company has completed the industrial and commercial registration changes for the acquisition of Shenzhou Borui[33]. Organizational Changes - The company has adjusted its organizational structure to enhance operational and management efficiency[33]. - The company has implemented new revenue recognition standards effective from January 1, 2020[146]. - The company has reclassified amounts related to completed performance obligations as contract assets under the new revenue standards[146].